ID3 and neoplasm: Remarkably, the Id1 and Id3 co-silencing in LS174T colon cancer cells in the same study, was able to increase the sensitivity of colon cancer-initiating cells to oxaliplatin, linking tumor initiation with chemotherapy resistance and underlying the potentially synergistic properties between Id1 and Id3 [25].